Zymeworks Completes Acquisition of Theravance Biopharma
Zymeworks Inc., a Nasdaq-listed biotechnology company, has completed the acquisition of Theravance Biopharma. This acquisition aims to advance Zymeworks' strategy to build a diversified, revenue-generating biotech company by combining innovative research and development with growing commercial and royalty-based cash flows. Zymeworks will discuss tr…